Developing a Digital Data-Driven Approach to preparing for FDA Inspections. Using Data Analytics to proactively monitor internal and external Quality & Compliance data sources.
Leveraging Technology to Empower Patients and Reduce Healthcare CostsPerficient, Inc.
Telehealth, once reserved for the chronically ill, is now being used to drive increased revenue by creating services that scale beyond traditional geographic boundaries.
Perficient and KP OnCall discussed how telehealth is impacting healthcare and how the nation’s leading telehealth provider is leveraging innovative technologies to:
-Reduce patient visits and lower healthcare costs
-Empower patients through self-treatment
-Deliver alternate methods of patient/provider communication
-Manage symptoms and medical conditions for the patients and populations they serve
-Generate data-driven insights
Reimagine patient safety 2030 governance through a unified safety platformVeeva Systems
Technology disruptions and healthcare transformation are shifting the roles of QPPV's and senior safety leaders to a more predictive, preventative and participatory safety ecosystem.
During the DIA QPPV Forum, Sharmila Sabaratnam, Senior Director Vault Safety Strategy, shared how you can improve collaboration, benefit-risk data flow and quality and generate insights to maximise patient outcome and minimise avoidable harm through medical governance oversight.
For more information visit:
www.veeva.com/eu/products/vault-safety
Disaster Recovery and Business Continuity for Your Clinical and Safety SystemsPerficient, Inc.
Your systems are up and running. You have no issues. It’s business as usual and all is as it should be. Then, suddenly, it’s not. A flood, an earthquake, a tornado or a fire threatens your organization’s ability to continue operating. Systems are offline, critical business processes have stalled. What damage has been inflicted? How long until you can recover? What do you do in the meantime? These are questions that no organization can properly answer without proper planning and testing.
The implications of an unplanned and unprepared-for event can be devastating to a company, as well as to the patients it serves. The only way to mitigate such risks is through comprehensive planning and testing.
Sean Bernard, lead business consultant in Perficient's life sciences practice, discussed why business continuity and disaster planning are so critical to life sciences companies, and shares best practices for preparing your company for the unforeseen.
Solving the Data Management Challenge for HealthcareDelphix
Need a proven blueprint to fast-track application development in your healthcare organization? With triple-digit growth, 3,000+ databases and over a petabyte of data, Molina Healthcare needed a way to accelerate application development and drive digital transformation.
Success meant slashing time to provision new dev and test environments in half, putting self-service data access in the hands of application teams―and doing it all without taking an eye off data security and HIPAA compliance.
Leveraging Technology to Empower Patients and Reduce Healthcare CostsPerficient, Inc.
Telehealth, once reserved for the chronically ill, is now being used to drive increased revenue by creating services that scale beyond traditional geographic boundaries.
Perficient and KP OnCall discussed how telehealth is impacting healthcare and how the nation’s leading telehealth provider is leveraging innovative technologies to:
-Reduce patient visits and lower healthcare costs
-Empower patients through self-treatment
-Deliver alternate methods of patient/provider communication
-Manage symptoms and medical conditions for the patients and populations they serve
-Generate data-driven insights
Reimagine patient safety 2030 governance through a unified safety platformVeeva Systems
Technology disruptions and healthcare transformation are shifting the roles of QPPV's and senior safety leaders to a more predictive, preventative and participatory safety ecosystem.
During the DIA QPPV Forum, Sharmila Sabaratnam, Senior Director Vault Safety Strategy, shared how you can improve collaboration, benefit-risk data flow and quality and generate insights to maximise patient outcome and minimise avoidable harm through medical governance oversight.
For more information visit:
www.veeva.com/eu/products/vault-safety
Disaster Recovery and Business Continuity for Your Clinical and Safety SystemsPerficient, Inc.
Your systems are up and running. You have no issues. It’s business as usual and all is as it should be. Then, suddenly, it’s not. A flood, an earthquake, a tornado or a fire threatens your organization’s ability to continue operating. Systems are offline, critical business processes have stalled. What damage has been inflicted? How long until you can recover? What do you do in the meantime? These are questions that no organization can properly answer without proper planning and testing.
The implications of an unplanned and unprepared-for event can be devastating to a company, as well as to the patients it serves. The only way to mitigate such risks is through comprehensive planning and testing.
Sean Bernard, lead business consultant in Perficient's life sciences practice, discussed why business continuity and disaster planning are so critical to life sciences companies, and shares best practices for preparing your company for the unforeseen.
Solving the Data Management Challenge for HealthcareDelphix
Need a proven blueprint to fast-track application development in your healthcare organization? With triple-digit growth, 3,000+ databases and over a petabyte of data, Molina Healthcare needed a way to accelerate application development and drive digital transformation.
Success meant slashing time to provision new dev and test environments in half, putting self-service data access in the hands of application teams―and doing it all without taking an eye off data security and HIPAA compliance.
Clinlogix - Improving Pharmacovigilance Outsourcing with Modern Technologies Veeva Systems
Learn how pharma companies and vendors are collaborating and simplifying processes with modern safety solutions. View the on-demand webinar here: https://bit.ly/30eAlJC
Pharmacovigilance Smart Sourcing Strategy: Vendor Selection for Safety & Risk...Covance
Strategic planning, sourcing and implementation of safety and risk management operations are complex activities that involve a multitude of factors. Due to the maturity of the outsourcing industry, compliant, quality and efficient safety operations are basic expectations now for the outsourcing of pharmacovigilance (PV) activities. This trend has enabled sponsors to focus their in-house resources on the strategic elements of safety and risk management while leveraging the service provider's capabilities.
Regulatory Intelligence Series - How to find Predicate Devices SOFIE compared...Graematter Inc
Regulatory Intelligence - FDA - How to find predicate devices.The SOFIE System, by Graematter, is a SaaS cloud based regulatory intelligence system for locating, analyzing and tracking regulatory information.
Tufts Research: Strategies from Data Management Leaders to Speed Clinical TrialsVeeva Systems
Watch the video here: https://bit.ly/3wChmGQ
Learn how top pharmas and CROs plan to speed database build and data collection, as well as their top challenges and future priorities. In this webinar you'll gain insights into:
* Taking an agile approach to database build
* Reducing UAT timelines with a risk-based approach
* Driving innovation at your organization
This in-depth research from Tufts follows their industry-wide eClinical Landscape Study, examining the major cause of database build delays and their impact on trial cycle times.
Meet Your Presenters:
Ken Getz
Director of Sponsored Programs, Tufts CSDD
Richard Young
Vice President, Vault EDC, Veeva Systems
Transform Your Digital Content to Improve Speed to Market While Maintaining C...Veeva Systems
Watch the full webinar to learn industry challenges and how Roche Diagnostics is transforming its digital content management with Veeva Vault PromoMats to improve speed to market:
https://go.veeva.com//transform-content-management-to-improve-speed-to-market
By better managing the lifecycle of digital assets, it will be possible to reduce expensive duplication of assets, maintain control of the brand image, and stay compliant in a complex regulatory environment.
The Benefits of a Seamless IRT and EDC Integration in Clinical Trial ExecutionVeeva Systems
Watch the video here: https://bit.ly/3upehbN
Veeva and Suvoda have combined their offerings into a powerful streamlined integration, which accommodates advanced study designs while driving down build and casebook complexity.
Hear Catherine Munera, head of biometrics at Cara Therapeutics, share the benefits of moving from a single provider to taking a harmonized, best-of-breed approach with IRT and EDC.
Best Practices for Managing Regulatory Binders ElectronicallyVeeva Systems
- Industry drivers for change and benefits of eRegulatory
- Tips for choosing the right system and evaluating a vendor
- Best practices and mistakes to avoid when going electronic
Health IT Summit Beverly Hills 2014 – “A Use Case…Thoughts on How to Leverage your Technology and The Cloud” with Raymond Lowe, Senior Director, Information Technology, Dignity Health
Reshaping Global ICSR Reporting to Deliver Real-time Visibility and OversightVeeva Systems
Learn how you can reshape global ICSR reporting to deliver real-time visibility and oversight.
In this presentation we discuss:
- Challenges and approaches to safety data management and ICRS reporting
- How technology is making it easier to comply with global and regional requirements
- Considerations for incorporating affiliates into one pharmacovigilance solution
- Strategies for adopting a single multi-lingual safety solution
View the on-demand webinar here: https://bit.ly/35Pfyik
This presentation reviews the regulatory requirements for intended use validation of SaaS-based EDC systems from the Sponsor and CRO perspective and provides best practices for implementing the proper validation in your organization.
Building a Foundation for Proactive and Predictive PharmacovigilanceVeeva Systems
Learn how PV teams can easily keep up with evolving compliance requirements with modern safety applications that provide better data control and drive greater efficiencies.
View on-demand session: https://bit.ly/3vIzQG9
The Industry’s Move Toward Digitally Connected Clinical TrialsVeeva Systems
The rapid adoption of decentralized trials is causing significant challenges – sites are burdened by too many technologies and the use of multiple patient-facing applications adds complexity for patients.
In these slides, we discuss the implications of decentralized trials, share findings from the Veeva Digital Clinical Trials Survey, and explore how clinical leaders are accelerating digital transformation to make studies more site and patient-centric.
Access the Veeva Digital Clinical Trials Survey Report (https://bit.ly/35eAeDn) for additional insights from more than 280 clinical leaders worldwide on the industry’s progress toward digital trial strategies, lessons learned, and what lies ahead.
Designing an EDC System to Work for a CRAVeeva Systems
Watch the video here: https://bit.ly/3h8gHIU
Targeted source data verification (SDV) might be well established, but many clinical teams are still verifying 100% of their data, making monitoring costly and inefficient.
By warching this on demand webinar, you will hear established RBM experts share the measures and metrics that organizations need to realize the true value of targeted SDV. Learn better ways to implement a risk-based strategy for SDV to ensure that CRAs focus on the most important data and how doing so can:
* Improve data quality
* Speed data collection and analysis
* Result in higher confidence and user satisfaction
Learn how Veeva is reinventing EDC to work for a CRA, creating significant speed and quality improvements.
Who Will Benefit:
Senior professionals working with clinical data/clinical documentation, including:
* Clinical Development/ R&D
* Clinical Data Management
* eClinical Operations
* Data Monitoring & Management
* Development Strategic Operations
* Information Strategy & Analytics, Clinical Informatics & Innovation
* Information Technology, R&D IT
* IT R&D Business Partner
Meet Your Presenters:
Drew Garty
Chief Technology Officer, Veeva Vault CDMS, Veeva
Drew Garty’s career in pharmaceutical technology spans over 20 years and includes significant expertise in EDC, clinical site monitoring, platform integrations and clinical trial management solutions. Drew’s innovative solutions in risk-based monitoring earned him a prestigious industry “Clinical Innovator of the Year” award in 2015. Drew joined Veeva in 2016 as Vice President of Product Management, and led the ground-up design of Veeva’s Vault EDC solution. In his current role of Chief Technology Officer at Vault CDMS, Drew shares and collaborates with customers, partners and the industry to set vision and direction of Veeva’s CDMS product.
Dawn Anderson
Managing Director, Life Sciences Strategy and Operations, Deloitte
Dawn has more than 30 years of industry and consulting experience in pharmaceutical, biotechnology, CROs, and technology companies. Her practice is focused on clinical development and she works with clients to design and deploy global operating strategy, performance improvement and technology implementations across the development of new drugs, biologics and devices. Dawn has spoken frequently about clinical transformation and the future of clinical trials, including topics around adaptive design, protocol complexity, risk assessments and the use of technology including virtual trials, digital, mHealth and the use of clinical analytics platforms and cognitive automation in transforming clinical trial delivery.
Clinlogix - Improving Pharmacovigilance Outsourcing with Modern Technologies Veeva Systems
Learn how pharma companies and vendors are collaborating and simplifying processes with modern safety solutions. View the on-demand webinar here: https://bit.ly/30eAlJC
Pharmacovigilance Smart Sourcing Strategy: Vendor Selection for Safety & Risk...Covance
Strategic planning, sourcing and implementation of safety and risk management operations are complex activities that involve a multitude of factors. Due to the maturity of the outsourcing industry, compliant, quality and efficient safety operations are basic expectations now for the outsourcing of pharmacovigilance (PV) activities. This trend has enabled sponsors to focus their in-house resources on the strategic elements of safety and risk management while leveraging the service provider's capabilities.
Regulatory Intelligence Series - How to find Predicate Devices SOFIE compared...Graematter Inc
Regulatory Intelligence - FDA - How to find predicate devices.The SOFIE System, by Graematter, is a SaaS cloud based regulatory intelligence system for locating, analyzing and tracking regulatory information.
Tufts Research: Strategies from Data Management Leaders to Speed Clinical TrialsVeeva Systems
Watch the video here: https://bit.ly/3wChmGQ
Learn how top pharmas and CROs plan to speed database build and data collection, as well as their top challenges and future priorities. In this webinar you'll gain insights into:
* Taking an agile approach to database build
* Reducing UAT timelines with a risk-based approach
* Driving innovation at your organization
This in-depth research from Tufts follows their industry-wide eClinical Landscape Study, examining the major cause of database build delays and their impact on trial cycle times.
Meet Your Presenters:
Ken Getz
Director of Sponsored Programs, Tufts CSDD
Richard Young
Vice President, Vault EDC, Veeva Systems
Transform Your Digital Content to Improve Speed to Market While Maintaining C...Veeva Systems
Watch the full webinar to learn industry challenges and how Roche Diagnostics is transforming its digital content management with Veeva Vault PromoMats to improve speed to market:
https://go.veeva.com//transform-content-management-to-improve-speed-to-market
By better managing the lifecycle of digital assets, it will be possible to reduce expensive duplication of assets, maintain control of the brand image, and stay compliant in a complex regulatory environment.
The Benefits of a Seamless IRT and EDC Integration in Clinical Trial ExecutionVeeva Systems
Watch the video here: https://bit.ly/3upehbN
Veeva and Suvoda have combined their offerings into a powerful streamlined integration, which accommodates advanced study designs while driving down build and casebook complexity.
Hear Catherine Munera, head of biometrics at Cara Therapeutics, share the benefits of moving from a single provider to taking a harmonized, best-of-breed approach with IRT and EDC.
Best Practices for Managing Regulatory Binders ElectronicallyVeeva Systems
- Industry drivers for change and benefits of eRegulatory
- Tips for choosing the right system and evaluating a vendor
- Best practices and mistakes to avoid when going electronic
Health IT Summit Beverly Hills 2014 – “A Use Case…Thoughts on How to Leverage your Technology and The Cloud” with Raymond Lowe, Senior Director, Information Technology, Dignity Health
Reshaping Global ICSR Reporting to Deliver Real-time Visibility and OversightVeeva Systems
Learn how you can reshape global ICSR reporting to deliver real-time visibility and oversight.
In this presentation we discuss:
- Challenges and approaches to safety data management and ICRS reporting
- How technology is making it easier to comply with global and regional requirements
- Considerations for incorporating affiliates into one pharmacovigilance solution
- Strategies for adopting a single multi-lingual safety solution
View the on-demand webinar here: https://bit.ly/35Pfyik
This presentation reviews the regulatory requirements for intended use validation of SaaS-based EDC systems from the Sponsor and CRO perspective and provides best practices for implementing the proper validation in your organization.
Building a Foundation for Proactive and Predictive PharmacovigilanceVeeva Systems
Learn how PV teams can easily keep up with evolving compliance requirements with modern safety applications that provide better data control and drive greater efficiencies.
View on-demand session: https://bit.ly/3vIzQG9
The Industry’s Move Toward Digitally Connected Clinical TrialsVeeva Systems
The rapid adoption of decentralized trials is causing significant challenges – sites are burdened by too many technologies and the use of multiple patient-facing applications adds complexity for patients.
In these slides, we discuss the implications of decentralized trials, share findings from the Veeva Digital Clinical Trials Survey, and explore how clinical leaders are accelerating digital transformation to make studies more site and patient-centric.
Access the Veeva Digital Clinical Trials Survey Report (https://bit.ly/35eAeDn) for additional insights from more than 280 clinical leaders worldwide on the industry’s progress toward digital trial strategies, lessons learned, and what lies ahead.
Designing an EDC System to Work for a CRAVeeva Systems
Watch the video here: https://bit.ly/3h8gHIU
Targeted source data verification (SDV) might be well established, but many clinical teams are still verifying 100% of their data, making monitoring costly and inefficient.
By warching this on demand webinar, you will hear established RBM experts share the measures and metrics that organizations need to realize the true value of targeted SDV. Learn better ways to implement a risk-based strategy for SDV to ensure that CRAs focus on the most important data and how doing so can:
* Improve data quality
* Speed data collection and analysis
* Result in higher confidence and user satisfaction
Learn how Veeva is reinventing EDC to work for a CRA, creating significant speed and quality improvements.
Who Will Benefit:
Senior professionals working with clinical data/clinical documentation, including:
* Clinical Development/ R&D
* Clinical Data Management
* eClinical Operations
* Data Monitoring & Management
* Development Strategic Operations
* Information Strategy & Analytics, Clinical Informatics & Innovation
* Information Technology, R&D IT
* IT R&D Business Partner
Meet Your Presenters:
Drew Garty
Chief Technology Officer, Veeva Vault CDMS, Veeva
Drew Garty’s career in pharmaceutical technology spans over 20 years and includes significant expertise in EDC, clinical site monitoring, platform integrations and clinical trial management solutions. Drew’s innovative solutions in risk-based monitoring earned him a prestigious industry “Clinical Innovator of the Year” award in 2015. Drew joined Veeva in 2016 as Vice President of Product Management, and led the ground-up design of Veeva’s Vault EDC solution. In his current role of Chief Technology Officer at Vault CDMS, Drew shares and collaborates with customers, partners and the industry to set vision and direction of Veeva’s CDMS product.
Dawn Anderson
Managing Director, Life Sciences Strategy and Operations, Deloitte
Dawn has more than 30 years of industry and consulting experience in pharmaceutical, biotechnology, CROs, and technology companies. Her practice is focused on clinical development and she works with clients to design and deploy global operating strategy, performance improvement and technology implementations across the development of new drugs, biologics and devices. Dawn has spoken frequently about clinical transformation and the future of clinical trials, including topics around adaptive design, protocol complexity, risk assessments and the use of technology including virtual trials, digital, mHealth and the use of clinical analytics platforms and cognitive automation in transforming clinical trial delivery.
Compliance with the FDA Guidances on Investigator Responsibilities and the Fo...Paul Below
This presentation was given at the North Texas Chapter ACRP Research Symposium, Dallas, TX (Aug 2011) and the SoCRA 20th Annual Conference, San Diego, CA (Sep 2011).
How to Prepare for an FDA Inspection and Respond to FDA 483's / Warning LettersGreenlight Guru
How long has it been since your last FDA inspection?
You know FDA is technically mandated to inspect any company with class II or class III products every two years (and inspections have been on the rise particularly for foreign / outside the US firms).
If FDA called tomorrow to announce their plans to visit your facility next week would you be prepared?
Even the most prepared companies still often find themselves receiving 483 observations.
Then you must act swiftly and effectively to avoid that observation escalating to a warning letter.
But what exactly do you do?
How do you respond to FDA 483 observations and/or warning letters?
greenlight.guru founder and VP QA/RA, Jon Speer, has been through his fair share of FDA inspections over the course of his 17+ year career in the medical device industry and has helped many of companies respond to 483 observations and warning letters along the way.
In this free, 60 minutes webinar, Jon will be sharing his most effective tips on how to avoid 483’s and warning letters in the first place along with a step-by-step guide to responding the them if you do happen to receive either.
(You can view the full webinar here: http://www.greenlight.guru/webinar/fda-483-warning-letter-response)
Specifically you'll learn:
What you should be doing to always be prepared for an FDA inspection
How to help prep your team before an FDA inspection
The top 7 reasons FDA issued medical device companies 483 observations and warning letters in FY2015
Tips you can implement today to mitigate your risk of getting 483’s and warning letters
What you need to do before responding to a 483 to minimize the damage (and avoid the common pitfalls)
Best practices for responding to FDA 483 and warning letter (including a free response template)
The differences in responding to a 483 observation vs. a warning letter
What to expect from FDA after submitting your response
In this presentation from Validation Week Europe, Karen Ginsbury discusses the rigors, preparations, strategies, and the do's and the don't of the FDA Inspection process.
Financial Services - New Approach to Data Management in the Digital Eraaccenture
How current is your data management strategy? As technology—and the requirements and business drivers around it—changes, financial services firms will need to change their approach to data management. To guide your approach, see the three building blocks to Accenture’s data management framework covered in this presentation.
In today's competitive market, many organizations are unaware of the quantity of poor-quality data in their systems. Some organizations assume that their data is of adequate quality, although they have conducted no metrical or statistical analysis to support the assumption. Others know that their performance is hampered by poor-quality data, but they cannot measure the problem.
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceGreenlight Guru
Understand the FDA's new draft guidance on Computer Software Assurance (CSA).
This presentation originally aired during the 2022 Future of QMS Requirements Virtual Summit.
RWE & Patient Analytics Leveraging Databricks – A Use CaseDatabricks
Gaining insights and knowledge from real-world health data (RWD), i.e., data acquired outside the context of randomized clinical trials, has been an area of continued opportunity for pharma organizations.
What is real-world data and real-world evidence – how it is generated, what value it drives for life sciences in general and what kind of analytics are performed.
What are some considerations and challenges related to data security, privacy, and industrialization of a big data platform hosted in the cloud.
How we leveraged Databricks to perform big data ingestion – advantages over native AWS Batch/Glue Examples of some of the advanced analytics use cases downstream that leveraged DB for RWE.
Note: This solution and one of the use case leveraging the solution won the 2020 Gartner Eye for Innovation award.
https://www.gartner.com/en/newsroom/press-releases/2020-11-17-gartner-announces-winners-of-the-2020-gartner-healthcare-and-life-sciences-eye-on-innovation-awardIn this
Moving to the Cloud: Modernizing Data Architecture in HealthcarePerficient, Inc.
Constant changes in the healthcare industry continue to drive innovation in technology and serve as a catalyst for cloud adoption. This trend will continue to evolve and accelerate in the coming years with the increasing need to store and analyze vast amounts of information for personal and population health initiatives.
We joined guest speaker from HIMSS Analytics, James Gaston, to discuss the impact of the cloud on data architecture in healthcare. Topics included:
-The benefits and risks of moving data and analytics environments to the cloud
-Main healthcare use cases for cloud migration
-Deep dive into two leading healthcare organizations’ cloud journeys including drivers, challenges, benefits, and lessons learned
With increased outsourcing of critical business functions it is more critical than ever to assess the risks posed by outside vendors and manage the ongoing relationship. In fact, regulators and auditors are focusing more and more on how vendors and contracts are managed and maintained by institutions. While vendor management is a “must-do” to satisfy financial industry regulatory requirements, it can also serve as a strategic initiative that can create a better run institution. Vendor Management can also be used as a way to improve efficiency, financial management, and profitability by reducing expenses and minimizing risk. Learn more at: www.nafcu.org/quantivate
A GLOBAL LIFE SCIENCES COMPANY IMPLEMENTS ADAPTIVEGRC SOLUTION SUITE FOR VARIOUS GRC SERVICES
The customer is a global Life Sciences company operating in over 50 international markets. With $5bn annual turnover it has more than 4000 employees.
Increasing Agility Through Data VirtualizationDenodo
During the Data Summit Conference in New York, our CMO Ravi Shankar and BJ Fesq, Chief Data Officer at CIT Group, were discussing the modernization of data architectures with data virtualization.
This presentation explores how data virtualization is being used to dramatically reduce data proliferation and ensure that all consumers are working with a single source of the truth. It also looks at how data virtualization can drive standardization, measure and improve data quality, abstract data consumers from data providers, expose data lineage, enable cross-company data integration, and serve as a common provisioning point from which to access all authoritative sources of data.
Discussion Forum data, sourced from sites like Reddit and other social media platforms, as well other sources of textual information, provides tremendous opportunity for insight and innovation. This presentation focuses on how an analysis of unstructured data can be used to innovate in Life/Health Science organizations
Similar to FDA News Webinar - Inspection Intelligence (20)
Explore our comprehensive data analysis project presentation on predicting product ad campaign performance. Learn how data-driven insights can optimize your marketing strategies and enhance campaign effectiveness. Perfect for professionals and students looking to understand the power of data analysis in advertising. for more details visit: https://bostoninstituteofanalytics.org/data-science-and-artificial-intelligence/
Opendatabay - Open Data Marketplace.pptxOpendatabay
Opendatabay.com unlocks the power of data for everyone. Open Data Marketplace fosters a collaborative hub for data enthusiasts to explore, share, and contribute to a vast collection of datasets.
First ever open hub for data enthusiasts to collaborate and innovate. A platform to explore, share, and contribute to a vast collection of datasets. Through robust quality control and innovative technologies like blockchain verification, opendatabay ensures the authenticity and reliability of datasets, empowering users to make data-driven decisions with confidence. Leverage cutting-edge AI technologies to enhance the data exploration, analysis, and discovery experience.
From intelligent search and recommendations to automated data productisation and quotation, Opendatabay AI-driven features streamline the data workflow. Finding the data you need shouldn't be a complex. Opendatabay simplifies the data acquisition process with an intuitive interface and robust search tools. Effortlessly explore, discover, and access the data you need, allowing you to focus on extracting valuable insights. Opendatabay breaks new ground with a dedicated, AI-generated, synthetic datasets.
Leverage these privacy-preserving datasets for training and testing AI models without compromising sensitive information. Opendatabay prioritizes transparency by providing detailed metadata, provenance information, and usage guidelines for each dataset, ensuring users have a comprehensive understanding of the data they're working with. By leveraging a powerful combination of distributed ledger technology and rigorous third-party audits Opendatabay ensures the authenticity and reliability of every dataset. Security is at the core of Opendatabay. Marketplace implements stringent security measures, including encryption, access controls, and regular vulnerability assessments, to safeguard your data and protect your privacy.
06-04-2024 - NYC Tech Week - Discussion on Vector Databases, Unstructured Data and AI
Discussion on Vector Databases, Unstructured Data and AI
https://www.meetup.com/unstructured-data-meetup-new-york/
This meetup is for people working in unstructured data. Speakers will come present about related topics such as vector databases, LLMs, and managing data at scale. The intended audience of this group includes roles like machine learning engineers, data scientists, data engineers, software engineers, and PMs.This meetup was formerly Milvus Meetup, and is sponsored by Zilliz maintainers of Milvus.